Prelude Therapeutics
PRLD
PRLD
49 hedge funds and large institutions have $22M invested in Prelude Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$171K | |
| 2 | +$82.3K | |
| 3 | +$74.3K | |
| 4 |
SC
Shay Capital
New York
|
+$60.7K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$58K |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$1.62M | |
| 3 | -$498K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$153K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$152K |
